Comparative In silico Analysis of Hypertrophic Cardiomyopathy Heart in Human and Normal Chicken Heart

Authors

  • Suganthi Karunanithi Sri Paramakalyani Centre for Environmental Sciences, Manonmaniam Sundaranar University, Alwarkurichi-627 412, Tirunelveli, Tamil Nadu, India.
  • Lakshmanan Venkatachalapathy Department of Cardio-Thoracic Surgery, MMC, Chennai-632003, Tamil Nadu, India.
  • Yamini Sudhalakshmi Department of Basic Health Sciences, Asmara College of Health Sciences, Asmara, Eritrea, Africa.
  • A. G. Murugesan Sri Paramakalyani Centre for Environmental Sciences, Manonmaniam Sundaranar University, Alwarkurichi-627 412, Tirunelveli, Tamil Nadu, India.
  • G. Thiyagarajan Department of Biotechnology, Central Leather Research Institute, Adyar, Chennai-600 020, Tamil Nadu, India.

Keywords:

Hypertrophic Cardiomyopathy, Beta-myosin Heavy Chain, CLUSTALW, Phylogenetic tree

Abstract

Hypertrophic Cardiomyopathy (HCM) is an incurable disease, which causes excessive thickening of the myocardium. HCM is caused by abnormalities in genes which code for the proteins responsible for contraction of the heart. The anatomical resemblances between the Chicken heart and HCM heart are thickening of the muscle of the left ventricle, localized ring- like thickening of muscle under the aortic valve, and poorly formed anterior ventricular groove, and left ventricle projecting beyond the right ventricle. The mutations for the genes are retrieved from the databases: Human Genome Mutation Database, Familial Hypertrophic Mutation Database and Cardiogenomics databases. Since the Beta-myosin Heavy Chain (MYH7) is more predominant in causing HCM, that gene alone is taken and compared with normal chicken heart myh7 gene. The amino acids were aligned by CLUSTAL W and they were found to have sequence homology of 85%. The phylogenetic tree was constructed by using PHYLIP to study evolutionary linkage. According to the results, it can be presumed that the chicken normal gene, during the evolutionary process have undergone many modifications and evolved as a complicated and advanced human heart.

Downloads

Download data is not yet available.

References

Botto, L.D., Robert-Gnansia, E., Siffel, C., Harris, J., Borman, B. & Mastroiacovo, P. (2006). Fostering international collaboration in birth defects research and prevention: a perspective from the International Clearinghouse for Birth Defects Surveillance and Research. Am. J. Public Health, 96(5): 774–780. https://doi.org/10.2105/AJPH.2004.057760.

Wellesley, D., Boyd, P., Dolk, H. & Pattenden, S. (2005). An aetiological classification of birth defects for epidemiological research. J. Med. Genet., 42(1): 54–57. https://doi.org/10.1136/jmg.2004.023309.

Rose, D.W. (2003). March of Dimes. Arcadia Publishing, Charleston, SC. pp. 128.

Watkins, M.L., Edmonds, L., McClearn, A., Mullins, L., Mulinare, J. & Khoury, M. (1996). The surveillance of birth defects: the usefulness of the revised US standard birth certificate. Am. J. Public Health, 86(5): 731-734. https://doi.org/10.2105/AJPH.86.5.731

Blaasaas, K.G., Tynes, T. & Lie, R.T. (2004). Risk of selected birth defects by maternal residence close to power lines during pregnancy. Occup. Environ. Med., 61(2): 174–176. http://dx.doi.org/10.1136/oem.2002.006239.

Brent, R.L. (2004). Environmental causes of human congenital malformations: the pediatrician's role in dealing with these complex clinical problems caused by a multiplicity of environmental and genetic factors. Pediatrics, 113: 957–968.

Hagège, A.A., Schwartz, K., Desnos, M. & Carrier, L. (2004). Genetic basis and genotype-phenotype relationships in familial hypertrophic cardiomyopathy. In: Maron, B.J. (ed.), Diagnosis and Management of Hypertrophic Cardiomyopathy. Blackwell Futura. pp. 67–80. https://doi.org/10.1002/9780470987469.ch3.

Ramírez, C.D. & Padrón, R. (2004). Familial hypertrophic cardiomyopathy: genes, mutations and animal models. A review. Invest. Clin., 45(1): 69–99.

Spirito, P., Piccininno, M. & Autore, C. (2004). Prevalence, Prevention and Treatment of Infective Endocarditis in Hypertrophic Cardiomyopathy. In: Maron, B.J. (ed.), Diagnosis and Management of Hypertrophic Cardiomyopathy. Blackwell Futura. pp. 195-199. https://doi.org/10.1002/9780470987469.ch13.

Mohiddin, S. & Fananapazir, L. (2001). Advances in understanding hypertrophic cardiomyopathy. Hosp. Pract., 36(5): 23–36. https://doi.org/10.3810/hp.2001.05.236.

Cuda, G., Fananapazir, L., Zhu, W.S., Sellers, J.R. & Epstein, N.D. (1993). Skeletal muscle expression and abnormal function of beta-myosin in hypertrophic cardiomyopathy. J. Clin. Invest., 91(6): 2861–2865. https://doi.org/10.1172/JCI116530.

Van Driest, S.L., Ackerman, M.J., Ommen, S.R., Shakur, R., Will, M.L., Nishimura, R.A., Tajik, A.J. & Gersh, B.J. (2002). Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy. Circulation, 106(24): 3085–3090. https://doi.org/10.1161/01.cir.0000042675.59901.14.

Yang, C. & Khuri, S. (2003). PTC: an interactive tool for phylogenetic tree construction. Proceedings of the Computational Systems Bioinformatics (CSB’03). IEEE Bioinformatics Conference. https://doi.org/10.1109/CSB.2003.1227378.

Venter, J.C., Adams, M.D., Myers, E.W., Li, P.W., Mural, R.J., Sutton, G.G., Smith, H.O., Yandell, M., Evans, C.A., Holt, R.A. et al. (2001). The sequence of the human genome. Science, 291: 1304–1351. https://doi.org/10.1126/science.1058040.

Check, E. (2002). Priorities for genome sequencing leave macaques out in the cold. Nature, 417: 473–474. https://doi.org/10.1038/417473a.

Epstein, N.D., Cohn, G.M., Cyran, F. & Fananapazir, L. (1992). Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation. Circulation, 86(2): 345–352. https://doi.org/10.1161/01.cir.86.2.345.

Rayment, I., Rypniewski, W.R., Schmidt-Bäse, K., Smith, R., Tomchick, D.R., Benning, M.M., Winkelmann, D.A., Wesenberg, G. & Holden, H.M. (1993). Three-dimensional structure of myosin subfragment-1: a molecular motor. Science, 261: 50–58. https://doi.org/10.1126/science.8316857.

Watkins, H., McKenna, W.J., Thierfelder, L., Suk, H.J., Anan, R., O'Donoghue, A., Spirito, P., Matsumori, A., Moravec, C.S., Seidman, J.G. & Seidman, C.E. (1995). Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. N. Engl. J. Med., 332(16): 1058–1064. https://doi.org/10.1056/NEJM199504203321603.

Giribet, G. (2002). Current advances in the phylogenetic reconstruction of metazoan evolution. A new paradigm for the Cambrian explosion? Mol. Phylogenet. Evol., 24(3): 345–357. https://doi.org/10.1016/s1055-7903(02)00206-3.

Olson, M.V. (1999). When less is more: gene loss as an engine of evolutionary change. Am. J. Hum. Genet., 64(1): 18–23. https://doi.org/10.1086/302219.

Downloads

Abstract views: 19 / PDF downloads: 5

Published

2010-07-01

How to Cite

Karunanithi, S., Venkatachalapathy, L., Sudhalakshmi, Y., Murugesan, A. G., & Thiyagarajan, G. (2010). Comparative In silico Analysis of Hypertrophic Cardiomyopathy Heart in Human and Normal Chicken Heart. Advances in BioScience, 1(1), 60–63. Retrieved from https://journals.sospublication.co.in/ab/article/view/3

Issue

Vol. 1 No. 1 (2010): July

Section

Articles

License

Copyright (c) 2010 The author(s) retains the copyright of this article.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.